September 17, 2014 7:07 PM ET

Capital Markets

Company Overview of Versant Ventures, Inc.

Company Overview

Versant Ventures is a venture capital firm specializing in incubation, seed, start-ups, and early stage investments. It seeks to invest in all segments of healthcare including, medical devices and diagnostics; med-tech; life sciences that include biopharmaceuticals and biotechnology platforms; healthcare services; and healthcare information technology. The firm prefers to invest in companies based in the United States and Western Europe. The firm seeks to invest in the biotechnology sector in Canada. The firm typically invests between $10 million and $20 million into each startup before it’s sold or goes public. It will not invest in a company unless it has at least $500 million in annualize...

3000 Sand Hill Road

Building 4

Suite 210

Menlo Park, CA 94025

United States

Founded in 1999

Phone:

650-233-7877

Fax:

650-854-9513

Key Executives for Versant Ventures, Inc.

Managing Director
Managing Director
Age: 59
Managing Director
Managing Director
Age: 61
Co-Founder and Managing Director
Age: 68
Compensation as of Fiscal Year 2014.

Versant Ventures, Inc. Key Developments

Roche, Inception Sciences, and Versant Ventures to Collaborate on MS Research

Roche (Switzerland) has entered into a partnership with Inception Sciences (US) and Versant Ventures (US) for the formation of a new company, Inception 5, which will focus on research and development of novel treatments for multiple sclerosis (MS). Inception 5 will research multiple molecular targets for remyelination that have already been identified, building a remyelination screening platform developed by investigators at the University of California.

Versant Ventures Expands Canadian Operations with Launch of Inception Sciences in Montreal

Versant Ventures continues its Canadian growth strategy with the launch of biopharmaceutical incubator Inception Sciences in Montreal. Versant, with Inception Sciences, will be working to launch new companies that can accelerate the commercialization of scientific research in the province of Quebec. Inception Sciences Montreal is another major commitment by Versant in Canada in the past year, following the launch of Blueline Bioscience in Toronto and Inception Sciences Vancouver. The launch of Montreal operations also adds a third research site to its Inception Sciences discovery engine to address the growing appetite of major pharmaceutical companies to enter innovative venture-backed partnerships. Inception Sciences Montreal is one of a number of recent activities for Versant in Canada. Versant recently formed a biotechnology incubator in Toronto, called Blueline Bioscience, which is collaborating with Celgene and aims to launch new companies in areas such as oncology and inflammation. Blueline Bioscience is headquartered in the MaRS Discovery District of Toronto and will announce the launch of its first spin out company in the next several months. In Vancouver, Versant established an office in 2013 and backed an Inception Sciences unit that is partnering with Bayer Healthcare to develop innovative therapeutics for retinal eye disease.

Versant Ventures, Inc. Presents at Washington Biotechnology & Biomedical Association 14th Annual Life Science Innovation Northwest 2014, Jun-19-2014 04:15 PM

Versant Ventures, Inc. Presents at Washington Biotechnology & Biomedical Association 14th Annual Life Science Innovation Northwest 2014, Jun-19-2014 04:15 PM. Venue: Washington State Convention Center, Seattle, Washington, United States. Speakers: Stefan Mathias Larson, Entrepreneur-in-Residence.

Similar Private Companies By Industry

Company Name Region
Benefit Capital Companies, Inc. United States
Beacon Acquisition Partners, Inc. United States
Dudack Research Group United States
Martel Capital, LLC United States
Garban Institutional Equities United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
August 27, 2014
WaveTec Vision Systems, Inc.
Private Placement
August 25, 2014
Mosaic Biomedicals SL
Private Placement
May 13, 2014
Ceterix Orthopedics, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Versant Ventures, Inc., please visit www.versantventures.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.